articleThe Journal of ImmunologyApr 1, 2003BRONZE OA

Cutting Edge: Cure of Colitis by CD4+CD25+ Regulatory T Cells

University of Oxford

PubMed
Indexed incrossrefpubmed

Abstract

CD4(+)CD25(+) regulatory T cells have been shown to prevent T cell-mediated immune pathology; however, their ability to ameliorate established inflammation has not been tested. Using the CD4(+)CD45RB(high) T cell transfer model of inflammatory bowel disease, we show that CD4(+)CD25(+) but not CD4(+)CD25(-)CD45RB(low) T cells are able to cure intestinal inflammation. Transfer of CD4(+)CD25(+) T cells into mice with colitis led to resolution of the lamina propria infiltrate in the intestine and reappearance of normal intestinal architecture. CD4(+)CD25(+) T cells were found to proliferate in the mesenteric lymph nodes and inflamed colon. They were located between clusters of CD11c(+) cells and pathogenic T cells…

Citation impact

918
total citations
FWCI
21.51
Percentile
100%
References
21
Citations per year

Authors

3

Topics & keywords

Keywords
  • IL-2 receptor
  • Colitis
  • Lamina propria
  • Inflammation
  • Mesenteric lymph nodes
  • Inflammatory bowel disease
  • Immunology
  • CD11c
UN Sustainable Development Goals
  • Good health and well-being
No related works found for this paper.